Buy or sell Zymergen stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Zymergen Stock

Biotechnology Company

Founded

2013

Notable Investors

Goldman Sachs

Headquarters

Emeryville CA, US

Total Funding

$970M

About Zymergen Stock

Zymergen is a biotechnology company that specializes in the fields of machine learning, big data, and artificial intelligence. The company partner with nature to create materials and products across industries from agriculture to electronics, consumer care to pharmaceuticals, and more. It was founded in 2013 and headquartered in Emeryville, California.

Investors

Funding History

June 2015$36.6M
June 2015$6.6M
October 2016$142M
November 2018$435M
July 2020$350M

Management

Chief Executive Officer

Joshua Hoffman

Chief Science Officer

Zach Serber

Chief Technology Officer

Aaron Kimball

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Zymergen or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 130K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo